| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 11/30/1999 | US5994519 Labelling proteins, peptides, or ligands by binding first marker ligand-enzyme conjugate to a specific binding pair member; binding label molecules to proteins, peptides, or ligands; isolating and/or purifying labelled product |
| 11/30/1999 | US5994495 Selectively functionalizable desdendrimers |
| 11/30/1999 | US5994060 Gro genes, proteins, and uses thereof |
| 11/30/1999 | US5993828 Administering to the subject an effective dose of a composition comprising inactivated tumor cells having urinary tumor associated antigen on the cell surface and at least one tumor associated antigen |
| 11/30/1999 | US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies |
| 11/30/1999 | US5993805 Spray-dried microparticles and their use as therapeutic vehicles |
| 11/30/1999 | US5993780 Contrast media |
| 11/30/1999 | US5993779 Interrupting an aorta at least at two sites, forming an isolated segment including branched parts of radicular arteries, feeding the spinal cord between the sites of interruption, bringing to ischemia, administering glu or asp |
| 11/30/1999 | US5993778 Functional expression of, and assay for, functional cellular receptors in vivo |
| 11/25/1999 | WO1999060131A2 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof |
| 11/25/1999 | WO1999060018A1 Labelled glutamine and lysine analogues |
| 11/25/1999 | WO1999059642A1 Labeled drugs and nitroxyl compounds to be used therein |
| 11/25/1999 | WO1999059641A1 Use of long-wavelength electromagnetic radiation of diagnosis |
| 11/25/1999 | WO1999059640A2 Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| 11/25/1999 | WO1999059632A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions |
| 11/25/1999 | WO1999059545A1 Targeted liposomal drug delivery system |
| 11/25/1999 | WO1998018500A8 Improvements in or relating to diagnostic/therapeutic agents |
| 11/25/1999 | CA2332277A1 Labelled glutamine and lysine analogues |
| 11/25/1999 | CA2329139A1 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof |
| 11/25/1999 | CA2328509A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions |
| 11/24/1999 | EP0959363A1 Magnetic resonance arteriography with dynamic,intravenous injection of contrast agents |
| 11/24/1999 | EP0958382A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 11/24/1999 | EP0958374A1 T1 receptor-like ligand i |
| 11/24/1999 | EP0957942A2 Polymer-lipid microencapsulated gases for use as imaging agents |
| 11/24/1999 | EP0957929A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 11/24/1999 | EP0902686B1 A process for the purification of opacifying contrast agents |
| 11/24/1999 | CN1236323A Administrable compositions nd method for magnetic resonance imaging |
| 11/24/1999 | CN1236322A Echogenic coating containing gaseous spaces for ultrasonography |
| 11/24/1999 | CN1046704C Iodinated derivatives, preparation and use thereof as contrast agents in X-ray radiology |
| 11/24/1999 | CN1046635C Composition and mether using nitrooxides to avoid oxygen toxicity |
| 11/23/1999 | US5990263 Contrast agents |
| 11/23/1999 | US5989907 Methods and compositions for calcium binding proteolipid encoding nucleic acids |
| 11/23/1999 | US5989520 Biotinylated lipid coated emulsion containing a paramagnetic element and a fluorochemical |
| 11/23/1999 | CA2176206C Harmonic ultrasound imaging with microbubbles |
| 11/18/1999 | WO1999058570A2 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use therefor for diagnosis and therapy of tumors and diseases associated with angiogenesis |
| 11/18/1999 | WO1999058162A2 Pharmaceuticals for the imaging of angiogenic disorders |
| 11/18/1999 | WO1999058161A1 Intramolecularly-quenched near infrared fluorescent probes |
| 11/18/1999 | WO1999058160A1 The use of a vital dye for facilitating surgical procedures for cataract extraction |
| 11/18/1999 | WO1999058159A1 The use of a vital dye for facilitating surgical procedures for vitreo-retinal surgery |
| 11/18/1999 | WO1999058158A1 Contrast media |
| 11/18/1999 | WO1999058139A2 Methods for detecting and inhibiting angiogenesis |
| 11/18/1999 | WO1999042076A9 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 11/18/1999 | CA2328414A1 Methods for detecting and inhibiting angiogenesis |
| 11/18/1999 | CA2324555A1 Pharmaceuticals for the imaging of angiogenic disorders |
| 11/17/1999 | EP0956865A1 MEDICINES COMPRISING Rho KINASE INHIBITOR |
| 11/17/1999 | EP0956290A1 Gp120 polypeptides having conformational discontinuous chemokine receptor binding sites and methods of inhibiting hiv infection |
| 11/17/1999 | EP0697884B1 Ligand precursors for incorporation into peptides |
| 11/16/1999 | US5986170 Murine model for human carcinoma |
| 11/16/1999 | US5986090 Metallized porphyrins |
| 11/16/1999 | US5986058 Growth differentiation factor with amino acid sequences |
| 11/16/1999 | US5985941 Blends, homogenizing to form emulsions |
| 11/16/1999 | US5985889 Dosage forms and method for ameliorating male erectile dysfunction |
| 11/16/1999 | US5985320 Drug delivery; medical diagnosis; genetic engineering; administering agent that interacts with cell surface receptors |
| 11/16/1999 | US5985247 Method for the production of microbubble-type ultrasonic contrast agent by surfactant |
| 11/16/1999 | US5985246 Contrast agents for ultrasonic imaging and methods for preparing the same |
| 11/16/1999 | US5985245 Contrast agents for MRI using a manganese compound and kojic acid |
| 11/16/1999 | US5985244 Suspension of a biocompatible polymer selected from the group consisting of polygalacturonic acid, polyglucuronic acid, polymannuronic acid and hyaluronic acid, |
| 11/16/1999 | US5985241 Diagnostic and radiodiagnostic agents, formed by reacting technetium-99m with a somatostatin receptor-binding peptide |
| 11/16/1999 | US5985240 Labeling somatostatin-derived peptides with perrhenate, treating rheumatoid arthritis, |
| 11/16/1999 | US5983899 Diagnostic method for establishing food intolerance/allergy, and an instrument for use when carrying out the method |
| 11/11/1999 | WO1999057151A2 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY |
| 11/11/1999 | WO1999056790A2 13c glucose breath test for the diagnosis of diabetes |
| 11/11/1999 | WO1999056789A1 Selection of contrast agent drug from a combinatorial library |
| 11/11/1999 | WO1999056788A1 Selection of targeted contrast agents from a combinatorial library |
| 11/11/1999 | WO1999056787A1 Selection of contrast agent from a combinatorial library |
| 11/11/1999 | WO1999056786A1 Diagnostic agent for mr diagnosis |
| 11/11/1999 | WO1999056759A1 Bone marrow cells as a source of neurons for brain and spinal cord repair |
| 11/11/1999 | WO1999056723A2 Hemoglobine-haptoglobin complexes for targeted drug delivery |
| 11/11/1999 | WO1999045016A9 Novel prodrugs for phosphorus-containing compounds |
| 11/11/1999 | DE19820847A1 Diagnostic agents for magnetic resonance imaging |
| 11/10/1999 | EP0955066A2 Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents |
| 11/10/1999 | EP0955065A1 Polyethylene glycol (PEG 4000) in a contrast medium composition for echography |
| 11/10/1999 | EP0955044A2 Method of inhibiting bacterial or fungal growth using a complexing agent |
| 11/10/1999 | EP0954529A1 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis |
| 11/10/1999 | EP0954336A2 Membrane incorporation of texaphyrins |
| 11/10/1999 | EP0708841B1 Method of identifying human and animal cells capable of unlimited proliferation or tumour formation |
| 11/10/1999 | CN1234742A Improvements in or relating to diagnostic/therapeutic agents and improvement relating to same |
| 11/10/1999 | CN1234405A High-effective broad-spectrum antibody for inhibiting growth and metastasis of tumour |
| 11/09/1999 | US5981755 Tachykinin antagonists |
| 11/09/1999 | US5981477 Peptide-metal chelate conjugates |
| 11/09/1999 | US5980937 Liposomes with enhanced entrapment capacity and their use in imaging |
| 11/09/1999 | US5980887 Methods for enhancing angiogenesis with endothelial progenitor cells |
| 11/09/1999 | US5980864 1,4,7,10-tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them |
| 11/09/1999 | US5980863 Manganese compositions and methods for MRI |
| 11/09/1999 | US5980862 Magnetic resonance imaging agents for the detection of physiological agents |
| 11/09/1999 | US5980860 Dopamine and serotonin transporter ligands and imaging agents |
| 11/09/1999 | US5980460 Ultrasound imaging |
| 11/09/1999 | CA2119129C Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media |
| 11/04/1999 | WO1999055837A2 Improvements in or relating to separation processes |
| 11/04/1999 | WO1999055670A2 Imidazol-like products and derivatives |
| 11/04/1999 | WO1999055387A1 Methods for detecting lesions in dense breast tissue using lhrh antagonists |
| 11/04/1999 | WO1999055384A1 Method and kit for obtaining fluids and cellular material from breast ducts |
| 11/04/1999 | WO1999055383A2 Improvements in or relating to diagnostic/therapeutic agents |
| 11/04/1999 | WO1999055230A1 Hyaluronan-based imaging agents |
| 11/04/1999 | WO1999034189A8 Process and device to solidify and thaw a polarized gas comprising xenon |
| 11/04/1999 | CA2329778A1 Improvements in or relating to diagnostic/therapeutic agents |
| 11/04/1999 | CA2329352A1 Methods for detecting lesions in dense breast tissue using lhrh antagonists |
| 11/04/1999 | CA2328698A1 Hyaluronan-based imaging agents |
| 11/03/1999 | EP0953639A1 FAPalpha-specific antibody with improved producibility |
| 11/03/1999 | EP0952853A2 Conjugate comprising an active agent, a polypeptide and a polyether |